Name: COEPTIS THERAPEUTICS HOLDING (COEP) Stock
Brand: COEPTIS THERAPEUTICS HOLDING
Rating: 5 (3 reviews)

COEP Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: ACCESS Newswire - Mentions: MDCX QNTM

Three Biotech Companies Redefining Value Creation Through Dual Strategies

2 months ago - By: Halper Sadeh LLC - Mentions: BFIN ARIS CIO

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates BFIN, COEP, ARIS, CIO on Behalf of Shareholders

2 months ago - By: ACCESS Newswire

Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage

2 months ago - By: Vanderbilt Report and Coeptis Therapeutics

Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating

4 months ago - By: Benzinga - Mentions: PBM IRIX TTNP HCTI ...

12 Health Care Stocks Moving In Thursday's After-Market Session

5 months ago - By: Coeptis Therapeutics

Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd

5 months ago - By: Coeptis Therapeutics

Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd

5 months ago - By: Halper Sadeh LLC - Mentions: SAGE AVDX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

5 months ago - By: Coeptis Therapeutics

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

5 months ago - By: Coeptis Therapeutics

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

6 months ago - By: Coeptis Therapeutics

Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology

6 months ago - By: Coeptis Therapeutics

Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology

7 months ago - By: Brodsky & Smith LLC - Mentions: SKX BSGM PPBI COLB

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSE - SKX), BioSig Technologies, Inc. (Nasdaq – BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.

7 months ago - By: Halper Sadeh LLC - Mentions: PPBI

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders

7 months ago - By: Brodsky & Smith LLC - Mentions: KRON RGLS PPBI COLB

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.

7 months ago - By: Benzinga - Mentions: RGC BCLI ZYXI RGLS ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

7 months ago - By: Halper Sadeh LLC - Mentions: OPTN SWTX CKPT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders

7 months ago - By: Halper Sadeh LLC

COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders

7 months ago - By: Coeptis Therapeutics

Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement

7 months ago - By: Coeptis Therapeutics

Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement

8 months ago - By: Coeptis Therapeutics

COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology

8 months ago - By: Coeptis Therapeutics

COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology

9 months ago - By: Coeptis Therapeutics

Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline

9 months ago - By: Coeptis Therapeutics

Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline

9 months ago - By: Coeptis Therapeutics

COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan

9 months ago - By: Coeptis Therapeutics - Mentions: BURU

COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan

10 months ago - By: Coeptis Therapeutics

COEPTIS’ NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network

10 months ago - By: Coeptis Therapeutics

COEPTIS THERAPEUTICS HOLDING (COEP) Stock News

COEP Latest News, Press Relases and Analysis